Effectiveness of Polypill for Prevention of Cardiovascular Disease (PolyPars): Protocol of a Randomized Controlled Trial

Fatemeh Malekzadeh ^1,2,3 , Abdullah Gandomkar ², Zinab Malekzadeh ¹, Hossein Poustchi ^1,4, Mohsen Moghadami ², Mohammad Reza Fattahi ⁵, Maryam Moini ⁵, Amir Anushiravani ^1,2, Roozbeh Mortazavi ⁶, Shahrokh Sadeghi Boogar ⁶, Vahid Mohammadkarimi ⁶, Firoozeh Abtahi ⁷, Shahin Merat ^1,8, Sadaf G. Sepanlou ¹ * , Reza Malekzadeh ^1,2,4,8

Cited by CrossRef: 1

1- Malekzadeh F, Gandomkar A, Poustchi H, Etemadi A, Roshandel G, Attar A, Abtahi F, Sadeghi Boogar S, Mohammadkarimi V, Fattahi M, Mohagheghi A, Malekzadeh R, Sepanlou S. Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars). Heart. 2024;:heartjnl-2023-323614 [Crossref]

2- Zhao C, Li S, Zhang J, Huang Y, Zhang L, Zhao F, Du X, Hou J, Zhang T, Shi C, Wang P, Huo R, Woodman O, Qin C, Xu H, Huang L. Current state and future perspective of cardiovascular medicines derived from natural products. Pharmacology & Therapeutics. 2020;216:107698 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.